{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:GB-COH-03877777-F327001", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "last-updated-datetime":"2025-03-05T04:19:42Z", "last_updated_datetime":"Wed Mar 05 04:19:42 UTC 2025", "last_updated_datetime_f":"2025-03-05T04:19:42Z", "lang":"en", "default_lang":"en", "default-currency":"USD", "default_currency":"USD", "humanitarian":false, "hierarchy":1, "iati-identifier":"GB-COH-03877777-F327001", "iati_identifier":"GB-COH-03877777-F327001", "reporting-org.type":"15", "reporting_org_type_code":"15", "reporting-org.ref":"GB-COH-03877777", "reporting_org_ref":"GB-COH-03877777", "reporting-org.secondary-reporter":false, "reporting_org_secondary_reporter":"0", "reporting-org.narrative":[" British International Investment plc"], "reporting_org_narrative":[" British International Investment plc"], "reporting-org.narrative.lang":["en"], "title.narrative":["Chemistry Holdings Limited"], "title_narrative":["Chemistry Holdings Limited"], "title_narrative_text":["Chemistry Holdings Limited"], "title.narrative.lang":[" "], "title_narrative_lang":[" "], "description.type":["1"], "description_type":["1"], "description.narrative":["Evercare and CDC Group have acquired a controlling interest in STS Holdings Ltd (STS). STS joins the Evercare network of hospitals that operate across South Asia and Africa and will provide immediate additional scale to the Evercare platform, significantly increasing the number of patients served."], "description_narrative":["Evercare and CDC Group have acquired a controlling interest in STS Holdings Ltd (STS). STS joins the Evercare network of hospitals that operate across South Asia and Africa and will provide immediate additional scale to the Evercare platform, significantly increasing the number of patients served."], "description_narrative_text":["Evercare and CDC Group have acquired a controlling interest in STS Holdings Ltd (STS). STS joins the Evercare network of hospitals that operate across South Asia and Africa and will provide immediate additional scale to the Evercare platform, significantly increasing the number of patients served."], "description.narrative.lang":[" "], "description_narrative_lang":[" "], "participating-org.ref":["GB-COH-03877777"], "participating_org_ref":["GB-COH-03877777"], "participating-org.type":["15"], "participating_org_type":["15"], "participating-org.role":["1"], "participating_org_role":["1"], "participating-org.narrative":["CDC Group Plc"], "participating_org_narrative":["CDC Group Plc"], "participating_org_narrative_text":["CDC Group Plc"], "participating-org.narrative.lang":[" "], "participating_org_narrative_lang":[" "], "activity-status.code":"2", "activity_status_code":"2", "activity-date.type":["2","1"], "activity_date_type":["2","1"], "activity-date.iso-date":["2019-12-19T00:00:00Z","2019-12-19T00:00:00Z"], "activity_date_iso_date":["2019-12-19T00:00:00Z","2019-12-19T00:00:00Z"], "contact-info.type":["4"], "contact_info_type":["4"], "contact-info.organisation.narrative":["Brisith International Investment plc"], "contact_info_organisation_narrative":["Brisith International Investment plc"], "contact_info_organisation_narrative_text":["Brisith International Investment plc"], "contact-info.organisation.narrative.lang":[" "], "contact_info_organisation_narrative_lang":[" "], "contact-info.department.narrative":["Communications Department"], "contact_info_department_narrative":["Communications Department"], "contact_info_department_narrative_text":["Communications Department"], "contact-info.department.narrative.lang":[" "], "contact_info_department_narrative_lang":[" "], "contact-info.telephone":["?+44 (0)20 7963 4700"], "contact_info_telephone":["?+44 (0)20 7963 4700"], "contact-info.email":["enquiries@bii.co.uk"], "contact_info_email":["enquiries@bii.co.uk"], "contact-info.website":["https://www.bii.co.uk"], "contact_info_website":["https://www.bii.co.uk"], "contact-info.mailing-address.narrative":["CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact_info_mailing_address_narrative":["CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact_info_mailing_address_narrative_text":["CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact-info.mailing-address.narrative.lang":[" "], "contact_info_mailing_address_narrative_lang":[" "], "recipient-region.code":["679"], "recipient_region_code":["679"], "recipient-region.percentage":[100.0], "recipient_region_percentage":[100.0], "recipient-region.vocabulary":["1"], "recipient_region_vocabulary":["1"], "sector.code":["12220"], "sector_code":["12220"], "sector.vocabulary":["1"], "sector_vocabulary":["1"], "collaboration-type.code":"6", "collaboration_type_code":"6", "default-flow-type.code":"10", "default_flow_type_code":"10", "default-aid-type.code":["C01"], "default_aid_type":["C01"], "default_aid_type_category_code":["C01"], "default_aid_type_code":["C01"], "default-aid-type.vocabulary":["1"], "default_aid_type_vocabulary":["1"], "default-tied-status.code":"5", "default_tied_status_code":"5", "transaction.transaction-type.code":["2"], "transaction_type":["2"], "transaction.transaction-date.iso-date":["2019-12-19T00:00:00Z"], "transaction_date_iso_date":["2019-12-19T00:00:00Z"], "transaction.value":[3.493463042E7], "transaction_value":[3.493463042E7], "transaction.description.narrative":["$45m commitment by CDC to Chemistry Holdings Limited"], "transaction_description_narrative":["$45m commitment by CDC to Chemistry Holdings Limited"], "transaction.description.narrative.lang":[" "], "transaction_description_lang":[" "], "transaction.provider-org.ref":["GB-COH-03877777"], "transaction_provider_org_ref":["GB-COH-03877777"], "transaction.provider-org.provider-activity-id":["GB-COH-03877777"], "transaction_provider_org_provider_activity_id":["GB-COH-03877777"], "transaction.provider-org.type":["70"], "transaction_provider_org_type":["70"], "transaction.provider-org.narrative":["CDC Group Plc"], "transaction_provider_org_narrative":["CDC Group Plc"], "transaction_provider_org_narrative_text":["CDC Group Plc"], "transaction.provider-org.narrative.lang":[" "], "transaction_provider_org_narrative_lang":[" "], "transaction.receiver-org.ref":["CDC Group Plc"], "transaction_receiver_org_ref":["CDC Group Plc"], "transaction.receiver-org.narrative":["Chemistry Holdings Limited"], "transaction_receiver_org_narrative":["Chemistry Holdings Limited"], "transaction_receiver_org_narrative_text":["Chemistry Holdings Limited"], "transaction.receiver-org.narrative.lang":[" "], "transaction_receiver_org_narrative_lang":[" "], "transaction.value.value-date":["2019-12-19T00:00:00Z"], "transaction_value_date":["2019-12-19T00:00:00Z"], "reporting-org.type.name":"Other Public Sector", "reporting_org_type_name":"Other Public Sector", "recipient-region.name":["South Asia, regional"], "recipient_region_name":["South Asia, regional"], "default-aid-type.name":["Project-type interventions"], "default_aid_type_category_name":["Project-type interventions"], "title.narrative.first":"Chemistry Holdings Limited", "title_narrative_first":"Chemistry Holdings Limited", "activity-date.start-actual":"2019-12-19T00:00:00Z", "activity_date_start_actual":"Thu Dec 19 00:00:00 UTC 2019", "activity_date_start_actual_f":"2019-12-19T00:00:00Z", "activity-date.common.start":"2019-12-19T00:00:00Z", "activity_date_start_common":"Thu Dec 19 00:00:00 UTC 2019", "activity_date_start_common_f":"2019-12-19T00:00:00Z", "activity-date.start-planned":"2019-12-19T00:00:00Z", "activity_date_start_planned":"Thu Dec 19 00:00:00 UTC 2019", "activity_date_start_planned_f":"2019-12-19T00:00:00Z", "activity-status.text":"Implementation", "activity_status_text":"Implementation", "transaction.value-usd.sum":3.493463042E7, "transaction_value_usd_sum":3.493463042E7, "transaction.value-usd.conversion-rate":[1.0], "transaction_usd_conversion_rate":[1.0], "transaction.value-usd.conversion-currency":["USD"], "transaction.value-gbp.sum":2.660679109044676E7, "transaction_value_gbp_sum":2.660679109044676E7, "transaction.value-gbp.conversion-rate":[1.3129967571528525], "transaction_gbp_conversion_rate":[1.3129967571528525], "transaction.value-gbp.conversion-currency":["USD"], "dataset.id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5", "dataset_iati_id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5", "dataset.name":"bii-activities", "dataset_name":"bii-activities", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"45892ebb68e2a1f3ed94b9d52c4bb262558a46e3", "dataset.resources.url":"https://aidstream.s3.us-west-2.amazonaws.com/xml/bii-activities.xml", "activity-date.quarter":[4,4], "transaction.transaction-date.quarter":[4], "transaction.value-usd":[3.493463042E7], "transaction_value_usd":[3.493463042E7], "transaction.value-usd-type":[2], "transaction.value-gbp":[2.660679109044676E7], "transaction_value_gbp":[2.660679109044676E7], "transaction.value-gbp-type":[2], "activity-aggregation.outgoing-commitment.value":3.493463042E7, "activity_aggregation_commitment_value":3.493463042E7, "activity-aggregation.outgoing-commitment.value-usd":3.493463042E7, "activity_aggregation_commitment_value_usd":3.493463042E7, "activity-aggregation.outgoing-commitment.value-gbp":2.660679109044676E7, "activity_aggregation_commitment_value_gbp":2.660679109044676E7, "json.reporting-org":"{\"type\": 15, \"ref\": \"GB-COH-03877777\", \"secondary-reporter\": 0, \"narrative\": \" British International Investment plc\", \"narrative.lang\": \"en\"}", "json.title":"{\"narrative\": \"Chemistry Holdings Limited\", \"narrative.lang\": \" \"}", "json.description":["{\"type\": 1, \"narrative\": \"Evercare and CDC Group have acquired a controlling interest in STS Holdings Ltd (STS). STS joins the Evercare network of hospitals that operate across South Asia and Africa and will provide immediate additional scale to the Evercare platform, significantly increasing the number of patients served.\", \"narrative.lang\": \" \"}"], "json.participating-org":["{\"ref\": \"GB-COH-03877777\", \"type\": 15, \"role\": 1, \"narrative\": \"CDC Group Plc\", \"narrative.lang\": \" \"}"], "json.activity-date":["{\"type\": 2, \"iso-date\": \"2019-12-19\"}","{\"type\": 1, \"iso-date\": \"2019-12-19\"}"], "json.contact-info":["{\"type\": 4, \"organisation\": {\"narrative\": \"Brisith International Investment plc\", \"narrative.lang\": \" \"}, \"department\": {\"narrative\": \"Communications Department\", \"narrative.lang\": \" \"}, \"telephone\": \"?+44 (0)20 7963 4700\", \"email\": \"enquiries@bii.co.uk\", \"website\": \"https://www.bii.co.uk\", \"mailing-address\": {\"narrative\": \"CDC Group plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom\", \"narrative.lang\": \" \"}}"], "json.recipient-region":["{\"code\": 679, \"percentage\": 100, \"vocabulary\": 1}"], "json.sector":["{\"code\": 12220, \"vocabulary\": 1}"], "json.default-aid-type":["{\"code\": \"C01\", \"vocabulary\": 1}"], "json.transaction":["{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2019-12-19\"}, \"value\": 34934630.42, \"description\": {\"narrative\": \"$45m commitment by CDC to Chemistry Holdings Limited\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"CDC Group Plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"ref\": \"CDC Group Plc\", \"narrative\": \"Chemistry Holdings Limited\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2019-12-19\"}"], "id":"98713e20-6dc7-4fa5-9c06-4561941f6ea3", "_version_":1862855425705115648 }] } }